Spindiag is a spin-off of Hahn-Schickard, one of the world’s leading research institutions for microsystems technology. Based on its patented microfluidic platform “LabDisk”, Spindiag develops an easy-to-use, compact, and automated point-of-care system for the broad, fast, and affordable screening for respiratory pathogens such as SARS-CoV-2 or drug-resistant pathogens.
Behavior guidelines:
https://www.spindiag.de/social-media-netiquette/
Company’s Keywords:
pointofcare testing & invitro diagnostics
<81
<
<2016